AKP-008 Clinical Study <Luteal phase support after in-vitro fertilization>
Phase 3
- Conditions
- uteal phase support after in-vitro fertilization
- Registration Number
- JPRN-jRCT2080222248
- Lead Sponsor
- ASKA Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Female partners of infertile married couples who want to conceive
-BMI<30
Exclusion Criteria
-Subjects with intraperitoneal abnormalities interfering with transvaginal ultrasound
-Subjects with uterine cavity abnormalities that preclude pregnancy
-Subjects with serious liver disorders or disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy rate and safety
- Secondary Outcome Measures
Name Time Method